Zevenbergen Capital Investments LLC Adaptive Biotechnologies Corp Transaction History

Zevenbergen Capital Investments LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$10.12 - $28.9 $7.07 Million - $20.2 Million	-698,859 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$25.17 - $36.85 $2.72 Million - $3.98 Million	-107,910 Reduced 13.38%	698,859 $19.6 Million
Q3 2021 Nov 12, 2021	SELL	$30.02 - $39.87 $6.67 Million - $8.86 Million	-222,345 Reduced 21.61%	806,769 $27.4 Million
Q2 2021 Aug 11, 2021	BUY	$32.22 - $44.59 $145,988 - $202,037	4,531 Added 0.44%	1,029,114 $42 Million
Q1 2021 May 12, 2021	BUY	$37.26 - $67.74 $1.02 Million - $1.85 Million	27,334 Added 2.74%	1,024,583 $41.3 Million
Q4 2020 Feb 10, 2021	BUY	$45.01 - $65.47 $207,496 - $301,816	4,610 Added 0.46%	997,249 $59 Million
Q3 2020 Nov 12, 2020	BUY	$35.79 - $48.81 $7.7 Million - $10.5 Million	215,049 Added 27.66%	992,639 $48.3 Million
Q2 2020 Aug 12, 2020	BUY	$24.95 - $48.38 $2.97 Million - $5.75 Million	118,940 Added 18.06%	777,590 $37.6 Million
Q1 2020 May 12, 2020	SELL	$16.96 - $34.16 $5.47 Million - $11 Million	-322,660 Closed	0 $0
Q4 2019 Feb 07, 2020	BUY	$24.56 - $32.8 $7.92 Million - $10.6 Million	322,660 New	322,660 $9.65 Million

202

146M

68.8K

42.5K

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $913M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

Get notified when there are updates to the investment portfolio of Zevenbergen Capital Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Zevenbergen Capital Investments LLC with notifications on news.